Esperion Therapeutics (ESPR) Total Debt Growth (1y) (2015 - 2026)
Esperion Therapeutics (ESPR) Total Debt Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.97 Bn | 36.23 Bn | 1.97 Bn | -0.14% |
| 2 | Zoetis | 33.59 Bn | 31.65 Bn | 1.62 Bn | 37.52% |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | - |
| 4 | Neurocrine Biosciences | 16.10 Bn | 14.78 Bn | 800.70 Mn | - |
| 5 | Aurora Cannabis | 15.56 Bn | 15.47 Bn | 21.72 Mn | - |
| 6 | Elanco Animal Health | 12.04 Bn | 11.61 Bn | 785.00 Mn | -9.19% |
| 7 | Alkermes | 7.36 Bn | 6.84 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.74 Bn | 6.24 Bn | 230.92 Mn | 0.63% |
| 9 | Liquidia | 6.27 Bn | 6.04 Bn | 121.79 Mn | - |
| 10 | Esperion Therapeutics | 49.69 Mn | -118.16 Mn | 45.53 Mn | 7.94% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.94% |
| Dec 31, 2025 | 7.98% |
| Jun 30, 2018 | -92.02% |
| Mar 31, 2018 | -74.03% |
| Dec 31, 2017 | -61.74% |
| Sep 30, 2017 | -52.79% |
| Jun 30, 2017 | -46.02% |
| Mar 31, 2017 | -40.64% |
| Dec 31, 2016 | -36.37% |
| Sep 30, 2016 | -32.80% |
| Jun 30, 2016 | -28.02% |
| Mar 31, 2016 | -19.92% |
| Dec 31, 2015 | -11.85% |
| Sep 30, 2015 | -5.42% |
| Jun 30, 2015 | -0.45% |